Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00069589 · ClinicalTrials.gov registry record
Alopecia Areata Registry
A clinical trial of Alopecia Areata and Alopecia Totalis, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- 3,100
- Enrollment target
- 5
- Study locations
NCT00069589: Active study of Alopecia Areata and Alopecia Totalis, sponsored by M.D. Anderson Cancer Center.
NCT00069589 is a study of Alopecia Areata and Alopecia Totalis that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 3,100 participants, above the 1,836-participant average among 26 other Alopecia Areata trials with a reported enrollment target (69% higher). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00069589, a study of Alopecia Areata and Alopecia Totalis, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 3,100 participants
- Enrollment target
- 5
- Study locations
Study Summary
Alopecia areata is the loss of hair in patches that can proceed to loss of all hair (alopecia totalis or universalis). The purpose of the registry is to collect patient information and blood samples from people with alopecia areata.
Primary Outcome
Database registration of participants via collection of participant epidemiology data.
Conditions Studied
Study Locations (5)
California
- University of California, San Francisco - San Francisco
Colorado
- University of Colorado - UCHSC - Health Science Center at Fitzsimons - Aurora
Minnesota
- University of Minnesota - Minneapolis
New York
- Columbia University - New York
Texas
- M.D. Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,100 participants |
| Start Date | 2001-11 |
| Est. Completion | 2099-11 |
What the registry record for NCT00069589 still lists
NCT00069589 is an observational study that tracks outcomes without assigning an intervention. Its 3,100 participants enrollment target places it among the larger protocols in the corpus, above the 1,836-participant average among 26 other Alopecia Areata trials with a reported enrollment target (69% higher).
The record links to 5 conditions, with Alopecia Areata appearing as the primary indexed condition, and to 0 interventions.
NCT00069589 lists 5 locations in 5 states (California, Colorado, Minnesota).
Frequently Asked Questions
What is clinical trial NCT00069589 about?
NCT00069589 is a clinical study titled "Alopecia Areata Registry". Alopecia areata is the loss of hair in patches that can proceed to loss of all hair (alopecia totalis or universalis). The purpose of the registry is to collect patient information and blood samples from people with alopecia areata.
What is the current status of trial NCT00069589?
This trial is currently active not recruiting. The enrollment target is 3,100 participants. The study started on 2001-11. Estimated completion is 2099-11.
What conditions does trial NCT00069589 study?
This clinical trial studies the following conditions: Alopecia Areata, Alopecia Totalis, Alopecia Universalis, Autoimmune Hair Loss, Alopecia Partialis.
Who is sponsoring clinical trial NCT00069589?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00069589 being conducted?
This trial has 5 study locations across California, Colorado, Minnesota, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alopecia Areata
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00069589's enrollment target sits among peer trials
3,100 4th of 26 higher than 23 of 26 other Alopecia Areata trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alopecia Areata trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
RECRUITING · Phase 2
-
A Study of LAD603 in Adults With Alopecia Areata
RECRUITING · Phase 2
-
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
RECRUITING · Phase 1
-
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
RECRUITING
-
Dupilumab in the Treatment of Pediatric Alopecia Areata
RECRUITING · Phase 2
-
Intralesional Cyclosporine for Alopecia Areata
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722822 · 3,100 participants · NA
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
- NCT05051722 · 3,110 participants
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- NCT05534243 · 3,090 participants · NA
The ED-AWARENESS-2 Trial
- NCT06667700 · 3,082 participants · Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia